{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:02:21Z","timestamp":1789524141785,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"EB Research Partnership"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05101-6","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T13:34:52Z","timestamp":1782567292000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of a long-term surviving human mesenchymal stromal cell subpopulation and implications for recessive dystrophic epidermolysis bullosa treatment"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3609-2942","authenticated-orcid":false,"given":"Mathilde","family":"Bonnet des Claustres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Gaucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Peltzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Luka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Nitschk\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3412-7512","authenticated-orcid":false,"given":"Alain","family":"Hovnanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7386-2769","authenticated-orcid":false,"given":"Matthias","family":"Titeux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"8","key":"5101_CR1","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1172\/JCI68127","volume":"123","author":"A Nystr\u00f6m","year":"2013","unstructured":"Nystr\u00f6m A, Velati D, Mittapalli VR, Fritsch A, Kern JS, Bruckner-Tuderman L. Collagen VII plays a dual role in wound healing. J Clin Invest ao\u00fbt. 2013;123(8):3498\u2013509.","journal-title":"J Clin Invest ao\u00fbt"},{"issue":"7","key":"5101_CR2","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.ajpath.2017.03.003","volume":"187","author":"F Cianfarani","year":"2017","unstructured":"Cianfarani F, Zambruno G, Castiglia D, Odorisio T. Pathomechanisms of Altered Wound Healing in Recessive Dystrophic Epidermolysis Bullosa. Am J Pathol juill. 2017;187(7):1445\u201353.","journal-title":"Am J Pathol juill"},{"issue":"4","key":"5101_CR3","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/14728214.2020.1839049","volume":"25","author":"M Titeux","year":"2020","unstructured":"Titeux M, Bonnet des Claustres M, Izmiryan A, Ragot H, Hovnanian A. Emerging drugs for the treatment of epidermolysis bullosa. Expert Opin Emerg Drugs d\u00e9c. 2020;25(4):467\u201389.","journal-title":"Expert Opin Emerg Drugs d\u00e9c"},{"issue":"5\u20136","key":"5101_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cytogfr.2009.10.002","volume":"20","author":"Lda Meirelles","year":"2009","unstructured":"Meirelles Lda, Fontes S, Covas AM, Caplan DT. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009;20(5\u20136):419\u201327.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"17","key":"5101_CR5","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s00018-019-03125-1","volume":"76","author":"A Naji","year":"2019","unstructured":"Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N. Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci sept. 2019;76(17):3323\u201348.","journal-title":"Cell Mol Life Sci sept"},{"issue":"1","key":"5101_CR6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13287-016-0363-7","volume":"7","author":"JL Spees","year":"2016","unstructured":"Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem\/stromal cell function. Stem Cell Res Ther d\u00e9c. 2016;7(1):125.","journal-title":"Stem Cell Res Ther d\u00e9c"},{"issue":"11","key":"5101_CR7","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1016\/j.jid.2018.04.028","volume":"138","author":"C Ganier","year":"2018","unstructured":"Ganier C, Titeux M, Gaucher S, Peltzer J, Le Lorc\u2019h M, Lataillade JJ, et al. Intradermal Injection of Bone Marrow Mesenchymal Stromal Cells Corrects Recessive Dystrophic Epidermolysis Bullosa in a Xenograft Model. J Invest Dermatology nov. 2018;138(11):2483\u20136.","journal-title":"J Invest Dermatology nov"},{"issue":"8","key":"5101_CR8","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1038\/mt.2015.58","volume":"23","author":"T K\u00fchl","year":"2015","unstructured":"K\u00fchl T, Mezger M, Hausser I, Handgretinger R, Bruckner-Tuderman L, Nystr\u00f6m A. High Local Concentrations of Intradermal MSCs Restore Skin Integrity and Facilitate Wound Healing in Dystrophic Epidermolysis Bullosa. Mol Therapy ao\u00fbt. 2015;23(8):1368\u201379.","journal-title":"Mol Therapy ao\u00fbt"},{"issue":"10","key":"5101_CR9","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/labinvest.2017.85","volume":"97","author":"BR Webber","year":"2017","unstructured":"Webber BR, O\u2019Connor KT, McElmurry RT, Durgin EN, Eide CR, Lees CJ, et al. Rapid generation of Col7a1-\/- mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells. Lab Invest oct. 2017;97(10):1218\u201324.","journal-title":"Lab Invest oct"},{"issue":"3","key":"5101_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3109\/14653241003587637","volume":"12","author":"P Conget","year":"2010","unstructured":"Conget P, Rodriguez F, Kramer S, Allers C, Simon V, Palisson F, et al. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy mai. 2010;12(3):429\u201331.","journal-title":"Cytotherapy mai"},{"issue":"9","key":"5101_CR11","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1038\/jid.2015.158","volume":"135","author":"G Petrof","year":"2015","unstructured":"Petrof G, Lwin SM, Martinez-Queipo M, Abdul-Wahab A, Tso S, Mellerio JE, et al. Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa. J Invest Dermatology sept. 2015;135(9):2319\u201321.","journal-title":"J Invest Dermatology sept"},{"issue":"2","key":"5101_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jaad.2019.11.038","volume":"83","author":"E Rashidghamat","year":"2020","unstructured":"Rashidghamat E, Kadiyirire T, Ayis S, Petrof G, Liu L, Pullabhatla V, et al. Phase I\/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa. J Am Acad Dermatology ao\u00fbt. 2020;83(2):447\u201354.","journal-title":"J Am Acad Dermatology ao\u00fbt"},{"issue":"7","key":"5101_CR13","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jcyt.2023.01.015","volume":"25","author":"K Dieter","year":"2023","unstructured":"Dieter K, Niebergall-Roth E, Daniele C, Fluhr S, Frank NY, Ganss C, et al. ABCB5\u2009+\u2009mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa. Cytotherapy juill. 2023;25(7):782\u20138.","journal-title":"Cytotherapy juill"},{"issue":"22","key":"5101_CR14","doi-asserted-by":"publisher","first-page":"e151922","DOI":"10.1172\/jci.insight.151922","volume":"6","author":"D Kiritsi","year":"2021","unstructured":"Kiritsi D, Dieter K, Niebergall-Roth E, Fluhr S, Daniele C, Esterlechner J, et al. Clinical trial of ABCB5\u2009+\u2009mesenchymal stem cells for recessive dystrophic epidermolysis bullosa. JCI Insight 22 nov. 2021;6(22):e151922.","journal-title":"JCI Insight 22 nov"},{"key":"5101_CR15","doi-asserted-by":"publisher","first-page":"576558","DOI":"10.3389\/fmed.2020.576558","volume":"7","author":"R Maseda","year":"2020","unstructured":"Maseda R, Mart\u00ednez-Santamar\u00eda L, Saced\u00f3n R, Butta N, de Arriba MDC, Garc\u00eda-Barcenilla S, et al. Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report. Front Med (Lausanne). 2020;7:576558.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"5101_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jid.2019.05.031","volume":"140","author":"A Petrova","year":"2020","unstructured":"Petrova A, Georgiadis C, Fleck RA, Allison L, McGrath JA, Dazzi F, et al. Human Mesenchymal Stromal Cells Engineered to Express Collagen VII Can Restore Anchoring Fibrils in Recessive Dystrophic Epidermolysis Bullosa Skin Graft Chimeras. J Invest Dermatology janv. 2020;140(1):121\u2013e1316.","journal-title":"J Invest Dermatology janv"},{"issue":"7","key":"5101_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods juill. 2012;9(7):676\u201382.","journal-title":"Nat Methods juill"},{"issue":"6282","key":"5101_CR18","first-page":"189","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Sci 8 avr. 2016;352(6282):189\u201396.","journal-title":"Sci 8 avr"},{"issue":"5","key":"5101_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. OMICS: J Integr Biology mai. 2012;16(5):284\u20137.","journal-title":"OMICS: J Integr Biology mai"},{"key":"5101_CR20","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","volume":"19","author":"M Andreatta","year":"2021","unstructured":"Andreatta M, Carmona SJ, UCell. Robust and scalable single-cell gene signature scoring. Comput Struct Biotechnol J. 2021;19:3796\u20138.","journal-title":"Comput Struct Biotechnol J"},{"key":"5101_CR21","doi-asserted-by":"publisher","unstructured":"Cao D, Chan RWS, Ng EHY, Gemzell-Danielsson K, Yeung WSB. Single-cell RNA sequencing of cultured human endometrial CD140b+CD146\u2009+\u2009perivascular cells highlights the importance of in vivo microenvironment. Stem Cell Res Ther [Internet]. d\u00e9c 2021 [cit\u00e9 8 juill 2025];12(1). Disponible sur: https:\/\/stemcellres.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s13287-021-02354-1","DOI":"10.1186\/s13287-021-02354-1"},{"issue":"25","key":"5101_CR22","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1016\/j.cell.2022.11.004","volume":"185","author":"S Sinha","year":"2022","unstructured":"Sinha S, Sparks HD, Labit E, Robbins HN, Gowing K, Jaffer A, et al. Fibroblast inflammatory priming determines regenerative versus fibrotic skin repair in reindeer. Cell 8 d\u00e9c. 2022;185(25):4717\u2013e473625.","journal-title":"Cell 8 d\u00e9c"},{"issue":"4","key":"5101_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"key":"5101_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.matbio.2018.12.001","volume":"81","author":"F Cianfarani","year":"2019","unstructured":"Cianfarani F, De Domenico E, Nystr\u00f6m A, Mastroeni S, Abeni D, Baldini E, et al. Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa. Matrix Biology ao\u00fbt. 2019;81:3\u201316.","journal-title":"Matrix Biology ao\u00fbt"},{"issue":"15","key":"5101_CR25","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.1093\/hmg\/ddu102","volume":"23","author":"T Odorisio","year":"2014","unstructured":"Odorisio T, Di Salvio M, Orecchia A, Di Zenzo G, Piccinni E, Cianfarani F, et al. Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-\u03b2 signalling in modifying disease severity. Hum Mol Genet 1 ao\u00fbt. 2014;23(15):3907\u201322.","journal-title":"Hum Mol Genet 1 ao\u00fbt"},{"issue":"8","key":"5101_CR26","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1038\/mt.2010.91","volume":"18","author":"M Titeux","year":"2010","unstructured":"Titeux M, Pendaries V, Zanta-Boussif MA, D\u00e9cha A, Pironon N, Tonasso L, et al. SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa. Mol Ther ao\u00fbt. 2010;18(8):1509\u201318.","journal-title":"Mol Ther ao\u00fbt"},{"issue":"16","key":"5101_CR27","doi-asserted-by":"publisher","first-page":"6609","DOI":"10.1073\/pnas.1016753108","volume":"108","author":"K Tamai","year":"2011","unstructured":"Tamai K, Yamazaki T, Chino T, Ishii M, Otsuru S, Kikuchi Y, et al. PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia. Proc Natl Acad Sci U S 19 avr. 2011;108(16):6609\u201314.","journal-title":"Proc Natl Acad Sci U S 19 avr"},{"issue":"19","key":"5101_CR28","doi-asserted-by":"publisher","first-page":"8639","DOI":"10.1073\/pnas.0911647107","volume":"107","author":"Y Kuroda","year":"2010","unstructured":"Kuroda Y, Kitada M, Wakao S, Nishikawa K, Tanimura Y, Makinoshima H, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci U S 11 mai. 2010;107(19):8639\u201343.","journal-title":"Proc Natl Acad Sci U S 11 mai"},{"issue":"1","key":"5101_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/15384101.2016.1211215","volume":"16","author":"N Alessio","year":"2017","unstructured":"Alessio N, \u00d6zcan S, Tatsumi K, Murat A, Peluso G, Dezawa M, et al. The secretome of MUSE cells contains factors that may play a role in regulation of stemness, apoptosis and immunomodulation. Cell Cycle 2 janv. 2017;16(1):33\u201344.","journal-title":"Cell Cycle 2 janv"},{"issue":"1","key":"5101_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5966\/sctm.2016-0014","volume":"6","author":"ML Gimeno","year":"2017","unstructured":"Gimeno ML, Fuertes F, Barcala Tabarrozzi AE, Attorressi AI, Cucchiani R, Corrales L, et al. Pluripotent Nontumorigenic Adipose Tissue-Derived Muse Cells have Immunomodulatory Capacity Mediated by Transforming Growth Factor-\u03b21. Stem Cells Translational Med 1 janv. 2017;6(1):161\u201373.","journal-title":"Stem Cells Translational Med 1 janv"},{"issue":"2","key":"5101_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/dth.12305","volume":"29","author":"M El-Darouti","year":"2016","unstructured":"El-Darouti M, Fawzy M, Amin I, Abdel Hay R, Hegazy R, Gabr H, et al. Treatment of dystrophic epidermolysis bullosa with bone marrow non-hematopoeitic stem cells: a randomized controlled trial. Dermatol Ther. 2016;29(2):96\u2013100.","journal-title":"Dermatol Ther"},{"issue":"1","key":"5101_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13287-022-02747-w","volume":"13","author":"S Alagesan","year":"2022","unstructured":"Alagesan S, Brady J, Byrnes D, Fandi\u00f1o J, Masterson C, McCarthy S, et al. Enhancement strategies for mesenchymal stem cells and related therapies. Stem Cell Res Ther d\u00e9c. 2022;13(1):75.","journal-title":"Stem Cell Res Ther d\u00e9c"},{"issue":"6","key":"5101_CR33","doi-asserted-by":"publisher","first-page":"C1562","DOI":"10.1152\/ajpcell.00221.2010","volume":"299","author":"SM Chacko","year":"2010","unstructured":"Chacko SM, Ahmed S, Selvendiran K, Kuppusamy ML, Khan M, Kuppusamy P. Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am J Physiol Cell Physiol d\u00e9c. 2010;299(6):C1562\u20131570.","journal-title":"Am J Physiol Cell Physiol d\u00e9c"},{"key":"5101_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/632902","volume":"2015","author":"S Lee","year":"2015","unstructured":"Lee S, Choi E, Cha MJ, Hwang KC. Cell Adhesion and Long-Term Survival of Transplanted Mesenchymal Stem Cells: A Prerequisite for Cell Therapy. Oxidative Med Cell Longev. 2015;2015:1\u20139.","journal-title":"Oxidative Med Cell Longev"},{"issue":"3","key":"5101_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/stem.2763","volume":"36","author":"A Moya","year":"2018","unstructured":"Moya A, Paquet J, Deschepper M, Larochette N, Oudina K, Denoeud C, et al. Human Mesenchymal Stem Cell Failure to Adapt to Glucose Shortage and Rapidly Use Intracellular Energy Reserves Through Glycolysis Explains Poor Cell Survival After Implantation. Stem Cells 1 mars. 2018;36(3):363\u201376.","journal-title":"Stem Cells 1 mars"},{"issue":"11","key":"5101_CR36","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1002\/stem.1499","volume":"31","author":"TJ Bartosh","year":"2013","unstructured":"Bartosh TJ, Yl\u00f6stalo JH, Bazhanov N, Kuhlman J, Prockop DJ. Dynamic compaction of human mesenchymal stem\/precursor cells into spheres self-activates caspase-dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1). Stem Cells 1 nov. 2013;31(11):2443\u201356.","journal-title":"Stem Cells 1 nov"},{"issue":"31","key":"5101_CR37","doi-asserted-by":"publisher","first-page":"13724","DOI":"10.1073\/pnas.1008117107","volume":"107","author":"TJ Bartosh","year":"2010","unstructured":"Bartosh TJ, Yl\u00f6stalo JH, Mohammadipoor A, Bazhanov N, Coble K, Claypool K, et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S 3 ao\u00fbt. 2010;107(31):13724\u20139.","journal-title":"Proc Natl Acad Sci U S 3 ao\u00fbt"},{"issue":"12","key":"5101_CR38","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1016\/j.jid.2023.05.021","volume":"143","author":"Y Kikuchi","year":"2023","unstructured":"Kikuchi Y, Tamakoshi T, Ishida R, Kobayashi R, Mori S, Ishida-Yamamoto A, et al. Gene-Modified Blister Fluid\u2013Derived Mesenchymal Stromal Cells for Treating Recessive Dystrophic Epidermolysis Bullosa. J Invest Dermatology d\u00e9c. 2023;143(12):2447\u2013e24558.","journal-title":"J Invest Dermatology d\u00e9c"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05101-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05101-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05101-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:18:56Z","timestamp":1789521536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05101-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5101"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05101-6","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the ethical principles of the Declaration of Helsinki. Human bone marrow samples were obtained as part of routine clinical procedures and were fully anonymized before being made available for research. All patients have given written informed consent to the inclusion and research use of their tissue samples. All samples used in this study were irreversibly anonymized prior to analysis and no identifying information was accessible to the investigators. According to the French Public Health Code (Article L1121-1) and the Loi Jard\u00e9, studies using previously collected and irreversibly anonymized human biological samples, without any intervention or interaction with participants, are classified as research not involving the human person (non-RIPH) and therefore do not require ethics committee approval.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the local animal welfare committee and performed in compliance with guidelines for animal experiments in France under the agreement 2018072716095485 given by the French ministry of research and higher education. Title of the project: \"Study of the pathophysiology and development of therapeutic approaches for dystrophic epidermolysis bullosa in mice \/ Etude de la physiopathologie et d\u00e9veloppement d\u2019approches th\u00e9rapeutiques pour les Epidermolyses Bulleuses Dystrophiques chez la souris\". Date of approval: 12 June 2020","order":2,"name":"Ethics","label":"Animal ethics declaration","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have not use AI-generated work in this manuscript","order":3,"name":"Ethics","label":"Artificial intelligence (AI)","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"318"}}